SCHEMBL1323167

SCHEMBL1323167

CCCP(C1CCCC1)C1CCCC1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.33
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA4 P22748 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL301104 0.97 CYP1A2 (0.37) CYP1A2CA1CA2CA4
SCHEMBL7535948 0.97 CYP1A2 (0.37) CYP1A2CA1CA2CA4
Ammonia Solution, Strong SCHEMBL4079351 0.95 CYP1A2 (0.36) CYP1A2
SCHEMBL27824835 0.89 CYP1A2 (0.32) CYP1A2
SCHEMBL28901892 0.89 CYP1A2 (0.32) CYP1A2
SCHEMBL1324543 0.84 CYP1A2 (0.41) CYP1A2
SCHEMBL1324612 0.84 CYP1A2 (0.41) CYP1A2
SCHEMBL9017493 0.82 CYP1A2 (0.44) CYP1A2
SCHEMBL1324548 0.82 CYP1A2 (0.39) CYP1A2
SCHEMBL1323174 0.82 CYP1A2 (0.39) CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111518145-A Cyanide-bridged metal organic compound with intramolecular magnetic transformation, and preparation method and application thereof 荆楚理工学院 2020-08-11 CN claimed
US-7067654-B2 Preparation of polyisocyanates containing uretdione groups BAYER MATERIALSCIENCE AG (DE) 2006-06-27 US claimed
US-20040110915-A1 for production of polyurethanes via catalytic polymerization with trimethylphosphine; improved storage stability BAYER AKTIENGESELLSCHAFT (DE) 2004-06-10 US claimed
US-20040106789-A1 Preparation of polyisocyanates containing uretdione groups COVESTRO DEUTSCHLAND AG (DE) 2004-06-03 US claimed
US-12492281-B2 Polyisocyanurate materials as electrical potting compounds COVESTRO DEUTSCHLAND AG (DE) 2025-12-09 US disclosed
CN-113631545-B Polyisocyanurate materials as electrical potting compounds 科思创德国股份有限公司 2025-01-07 CN disclosed
CN-111518145-B Cyano-bridged metal organic compound with intramolecular magnetic transformation and preparation method and application thereof 荆楚理工学院 2023-06-20 CN disclosed
CN-108884010-B Process for preparing unsaturated carboxylic acid salts 巴斯夫欧洲公司 2022-11-08 CN disclosed
EP-3794049-B1 METHOD FOR PRODUCING A POLYISOCYANATE POLYMER AND A POLYISOCYANURATE PLASTIC COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2022-06-08 EP disclosed
US-11319402-B2 Method for producing a polyisocyanate polymer and a polyisocyanurate plastic COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2022-05-03 US disclosed
US-20220127407-A1 POLYISOCYANURATE MATERIALS AS ELECTRICAL POTTING COMPOUNDS COVESTRO DEUTSCHLAND AG (DE) 2022-04-28 US disclosed
CN-106458823-B Process for preparing unsaturated carboxylic acid salts 巴斯夫欧洲公司 2022-04-19 CN disclosed
US-20060173152-A1 Uretdione formation in solution BAYER MATERIALSCIENCE AG 2006-08-03 US disclosed
EP-1683818-A2 Uretdione formation in solution Bayer MaterialScience AG (DE) 2006-07-26 EP disclosed
US-7067654-B2 Preparation of polyisocyanates containing uretdione groups BAYER MATERIALSCIENCE AG (DE) 2006-06-27 US disclosed
US-20040110915-A1 for production of polyurethanes via catalytic polymerization with trimethylphosphine; improved storage stability BAYER AKTIENGESELLSCHAFT (DE) 2004-06-10 US disclosed
EP-1426393-A2 Low monomer urethdione-groups containing polyisocyanates Bayer MaterialScience AG (DE) 2004-06-09 EP disclosed
US-20040106789-A1 Preparation of polyisocyanates containing uretdione groups COVESTRO DEUTSCHLAND AG (DE) 2004-06-03 US disclosed
EP-1422223-A1 Preparation of polyisocyanates containing uretdione groups with cycloalkylphosphines as catalysts Bayer MaterialScience AG (DE) 2004-05-26 EP disclosed
US-4595701-A Reacting carbon monoxide and hydrogen in liquid phase in the presence of a rhodium and trialkylphosphine catalyst AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 1986-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040106789-A1 Preparation of polyisocyanates containing uretdione groups UROD, PUF60, UTS2R CYP1A2 905/4885CA1 3661/4885CA2 3625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.